BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
DTSTART:20250309T030000
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:PDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20241103T010000
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:PST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20250308T222926Z
UID:AC2EB3CA-C1CB-4581-A0B4-3970038D6A32
DTSTART;TZID=America/Los_Angeles:20250307T120000
DTEND;TZID=America/Los_Angeles:20250307T140000
DESCRIPTION:Welcome to the 2nd lecture!\n\nWe went over the following in th
 e last lecture:\n\n- Learned the basics of AI and ML\n- How is AI/ML relat
 ed to biological networks\n- How an AI system is trained and what does it 
 mean\n- Why\, how\, and where AI/ML helps\n\nAI is generally applied to th
 e detection or presence of a certain disease. The manner in which it can b
 e used to solve differs on the problem construction. In some cases\, the t
 raining is done on actual images\, or images are constructed from the data
  itself\, or time series analysis are done etc. Also\, depending upon the 
 problem\, it may be useful to consider what type of network should be used
 : CNN\, DNN\, RNN\, LSTM etc.\n\nWe will start with an understanding of so
 me biological signals that are necessary to solve a certain detection or e
 stimation problem.\n\nWe will review the following examples:\n\n- Imaging 
 – detection of abnormalities in a CT scan\, MRI\, or X-ray\,\n- Detectio
 n of Atrial Fibrillation using:\n- Time series analysis\n- Image analysis\
 n\n- Drug discovery\,\n- Help in diagnosis of a disease (automated doctor?
 )\, and\n- LLM in medicine\n\nHow AI is used to develop an algorithm is di
 fferent from how the medical devices were made in the past. AI generally r
 equires large databases and also may or may not work on known features or 
 aspects of a disease. In some cases\, the data scientist expects AI to fig
 ure out such features. This poses a challenge to the regulating authoritie
 s that the detection of a disease is done without knowing how it was done.
  We will review how and what FDA is doing about it.\n\nIf time permits\, w
 e will go over some cautions around data analysis.\n\nSpeaker(s): Dr Md Us
 man\n\nAgenda: \n- 12:10 to 12:20 PM : Introduction by Gora Datta\, FHL7\n
 - 12:20 to 1::55 PM: Expert Lecture by Dr Md Usman\n- Understand some exam
 ples of using AI\,\n- Know when to use AI for health measurements\,\n- Reg
 ulations around AI by the FDA.\n\n- 1:55 to 2 PM : Wrap Up\n\nRoom: Shark 
 Cove\, Bldg: Bealle Applied Innovation\, 5270 California Ave\, Irvine\, Ca
 lifornia\, United States\, 92617\, Virtual: https://events.vtools.ieee.org
 /m/472277
LOCATION:Room: Shark Cove\, Bldg: Bealle Applied Innovation\, 5270 Californ
 ia Ave\, Irvine\, California\, United States\, 92617\, Virtual: https://ev
 ents.vtools.ieee.org/m/472277
ORGANIZER:goradatta@ieee.org
SEQUENCE:14
SUMMARY:MEDICAL DEVICES PART II- Public Health and FDA Regulations
URL;VALUE=URI:https://events.vtools.ieee.org/m/472277
X-ALT-DESC:Description: &lt;br /&gt;&lt;p&gt;Welcome to the 2&lt;sup&gt;nd&lt;/sup&gt;&amp;nbsp\;lectur
 e!&lt;/p&gt;\n&lt;p&gt;We went over the following in the last lecture:&lt;/p&gt;\n&lt;ul&gt;\n&lt;li&gt;
 Learned the basics of AI and ML&lt;/li&gt;\n&lt;li&gt;How is AI/ML related to biologic
 al networks&lt;/li&gt;\n&lt;li&gt;How an AI system is trained and what does it mean&lt;/l
 i&gt;\n&lt;li&gt;Why\, how\, and where AI/ML helps&lt;/li&gt;\n&lt;/ul&gt;\n&lt;p&gt;AI is generally 
 applied to the detection or presence of a certain disease. The manner in w
 hich it can be used to solve differs on the problem construction. In some 
 cases\, the training is done on actual images\, or images are constructed 
 from the data itself\, or time series analysis are done etc. Also\, depend
 ing upon the problem\, it may be useful to consider what type of network s
 hould be used: CNN\, DNN\, RNN\, LSTM etc.&lt;/p&gt;\n&lt;p&gt;We will start with an u
 nderstanding of some biological signals that are necessary to solve a cert
 ain detection or estimation problem.&lt;/p&gt;\n&lt;p&gt;We will review the following 
 examples:&lt;/p&gt;\n&lt;ol&gt;\n&lt;li&gt;Imaging &amp;ndash\; detection of abnormalities in a 
 CT scan\, MRI\, or X-ray\,&lt;/li&gt;\n&lt;li&gt;Detection of Atrial Fibrillation usin
 g:\n&lt;ol&gt;\n&lt;li&gt;Time series analysis&lt;/li&gt;\n&lt;li&gt;Image analysis&lt;/li&gt;\n&lt;/ol&gt;\n&lt;
 /li&gt;\n&lt;li&gt;Drug discovery\,&lt;/li&gt;\n&lt;li&gt;Help in diagnosis of a disease (autom
 ated doctor?)\, and&lt;/li&gt;\n&lt;li&gt;LLM in medicine&lt;/li&gt;\n&lt;/ol&gt;\n&lt;p&gt;How AI is us
 ed to develop an algorithm is different from how the medical devices were 
 made in the past. AI generally requires large databases and also may or ma
 y not work on known features or aspects of a disease. In some cases\, the 
 data scientist expects AI to figure out such features. This poses a challe
 nge to the regulating authorities that the detection of a disease is done 
 without knowing how it was done. We will review how and what FDA is doing 
 about it.&lt;/p&gt;\n&lt;p&gt;If time permits\, we will go over some cautions around d
 ata analysis.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;Agenda: &lt;br /&gt;&lt;ul&gt;\n&lt;li&gt;12:10 to 12:20 PM : I
 ntroduction by Gora Datta\, FHL7&lt;/li&gt;\n&lt;li aria-level=&quot;1&quot;&gt;12:20 to 1::55 P
 M: Expert Lecture by Dr Md Usman\n&lt;ul&gt;\n&lt;li&gt;Understand some examples of us
 ing AI\,&lt;/li&gt;\n&lt;li&gt;Know when to use AI for health measurements\,&lt;/li&gt;\n&lt;li
 &gt;Regulations around AI by the FDA.&lt;/li&gt;\n&lt;/ul&gt;\n&lt;/li&gt;\n&lt;li aria-level=&quot;1&quot;&gt;
 1:55 to 2 PM : Wrap Up&lt;/li&gt;\n&lt;/ul&gt;
END:VEVENT
END:VCALENDAR

